Tempest raises $4.25M upfront in registered direct offering; warrants add up to $4.1M

Tempest Therapeutics, Inc.

1,172,414 shares (or equivalents) sold at $3.625/share in registered direct offering for ~$4.25M gross.
Concurrent private placement of short-term warrants to buy 1,172,414 shares at $3.50, exercisable for 18 months.
Warrants could yield additional ~$4.1M proceeds if fully exercised on a cash basis, but no guarantee.
Net proceeds used for working capital and general corporate purposes; H.C. Wainwright placement agent with 6% fee.

Key facts

Extracted from this filing and checked against the source text.

Equity Issuances SEC 8-K Item 3.02/3.03 confidence 0.9

Tempest Therapeutics, Inc. issued warrants to purchase up to an aggregate of 1,172,414 shares of common stock of warrant to a single healthcare-focused institutional investor for exercise price of $3.50 per share.

Security: warrant
Shares: warrants to purchase up to an aggregate of 1,172,414 shares of common stock
Purchaser: a single healthcare-focused institutional investor
Consideration: exercise price of $3.50 per share

Exact text from the filing

in a concurrent private placement, the Company will issue and sell short-term unregistered warrants to purchase up to an aggregate of 1,172,414 shares of common stock at an exercise price of $3.50 per share

View on SEC.gov

Equity Issuances SEC 8-K Item 3.02/3.03 confidence 0.9

Tempest Therapeutics, Inc. issued 1,172,414 shares of its common stock (or common stock equivalents) of common stock to a single healthcare-focused institutional investor for $3.625 per share.

Security: common stock
Shares: 1,172,414 shares of its common stock (or common stock equivalents)
Purchaser: a single healthcare-focused institutional investor
Consideration: $3.625 per share

Exact text from the filing

the purchase and sale of 1,172,414 shares of its common stock (or common stock equivalents), at an offering price of $3.625 per share of common stock (or common stock equivalent) in a registered direct offering priced at-the-market under Nasdaq rules

View on SEC.gov

32 equity issuances filed in the last 30 days. Browse all equity issuances →

Tempest Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-25-298604

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.